Micafungin therapy in a critically ill, morbidly obese patient

被引:14
|
作者
Zomp, Amanda [2 ]
Bookstaver, P. Brandon [1 ]
Ahmed, Yasir [3 ]
Turner, J. Elliot
King, Christie [4 ]
机构
[1] Univ S Carolina, Dept Clin Pharm & Outcomes Sci, S Carolina Coll Pharm, Columbia, SC 29208 USA
[2] Palmetto Hlth Richland, Dept Pharm, Columbia, SC 29203 USA
[3] Univ S Carolina, Sch Med, Div Infect Dis, Dept Internal Med, Columbia, SC 29203 USA
[4] Med Univ S Carolina, S Carolina Coll Pharm, Charleston, SC 29425 USA
关键词
echinocandins; obesity; candidiasis; pharmacokinetics; ADULT PATIENTS; PHARMACOKINETICS;
D O I
10.1093/jac/dkr323
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:2678 / 2680
页数:4
相关论文
共 50 条
  • [31] TRANSFUSION THERAPY IN THE CRITICALLY ILL PATIENT
    CHANATRY, BJ
    GETTINGER, A
    [J]. INTERNATIONAL ANESTHESIOLOGY CLINICS, 1993, 31 (02) : 73 - 95
  • [32] INOTROPIC THERAPY IN THE CRITICALLY ILL PATIENT
    LINDEBORG, DM
    PEARL, RG
    [J]. INTERNATIONAL ANESTHESIOLOGY CLINICS, 1993, 31 (02) : 49 - 71
  • [33] Caring for the Critically Ill Obese Patient: Challenges and Opportunities
    Winfield, Robert D.
    [J]. NUTRITION IN CLINICAL PRACTICE, 2014, 29 (06) : 747 - 750
  • [34] Bedside and Radiologic Procedures in the Critically Ill Obese Patient
    Olson, Michelle
    Pohl, Chris
    [J]. CRITICAL CARE CLINICS, 2010, 26 (04) : 665 - +
  • [35] Antifungal Lock Therapy With Combined 70% Ethanol and Micafungin in a Critically Ill Infant
    Piersigilli, Fiammetta
    Auriti, Cinzia
    Bersani, Iliana
    Goffredo, Bianca
    Bianco, Giuseppe
    Savarese, Imma
    Dotta, Andrea
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (04) : 419 - 420
  • [36] Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
    Young R. Lee
    Delilah D. Blanco
    [J]. Journal of Thrombosis and Thrombolysis, 2017, 44 : 386 - 391
  • [37] Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
    Lee, Young R.
    Blanco, Delilah D.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (03) : 386 - 391
  • [38] Pharmacokinetic Analysis of Piperacillin Administered with Tazobactam in Critically Ill, Morbidly Obese Surgical Patients
    Sturm, Ashley W.
    Allen, Nichole
    Rafferty, Kelly D.
    Fish, Douglas N.
    Toschlog, Eric
    Newell, Mark
    Waibel, Brett
    [J]. PHARMACOTHERAPY, 2014, 34 (01): : 28 - 35
  • [39] A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients.
    El Solh, Ali A.
    Jaafar, Wafaa
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (12) : A95 - A95
  • [40] PROTEIN-SPARING MODIFIED-FAST TOTAL PARENTERAL-NUTRITION FORMULATION FOR A CRITICALLY ILL MORBIDLY OBESE PATIENT
    SHIKORA, SA
    MUSKAT, PC
    [J]. NUTRITION, 1994, 10 (02) : 155 - 158